139 related articles for article (PubMed ID: 8383771)
1. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
Kim KH; Willingmann P; Gong ZX; Kremer MJ; Chapman MS; Minor I; Oliveira MA; Rossmann MG; Andries K; Diana GD
J Mol Biol; 1993 Mar; 230(1):206-27. PubMed ID: 8383771
[TBL] [Abstract][Full Text] [Related]
2. Human rhinovirus 3 at 3.0 A resolution.
Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of human rhinovirus serotype 1A (HRV1A).
Kim SS; Smith TJ; Chapman MS; Rossmann MC; Pevear DC; Dutko FJ; Felock PJ; Diana GD; McKinlay MA
J Mol Biol; 1989 Nov; 210(1):91-111. PubMed ID: 2555523
[TBL] [Abstract][Full Text] [Related]
4. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
[TBL] [Abstract][Full Text] [Related]
7. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.
Grant RA; Hiremath CN; Filman DJ; Syed R; Andries K; Hogle JM
Curr Biol; 1994 Sep; 4(9):784-97. PubMed ID: 7820548
[TBL] [Abstract][Full Text] [Related]
8. Trypsin sensitivity of several human rhinovirus serotypes in their low pH-induced conformation.
Kowalski H; Maurer-Fogy I; Vriend G; Casari G; Beyer A; Blaas D
Virology; 1989 Aug; 171(2):611-4. PubMed ID: 2548332
[TBL] [Abstract][Full Text] [Related]
9. Human rhinovirus 14 complexed with fragments of active antiviral compounds.
Bibler-Muckelbauer JK; Kremer MJ; Rossmann MG; Diana GD; Dutko FJ; Pevear DC; McKinlay MA
Virology; 1994 Jul; 202(1):360-9. PubMed ID: 8009848
[TBL] [Abstract][Full Text] [Related]
10. The structure of human rhinovirus 16.
Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the three-dimensional structure of two human rhinoviruses (HRV2 and HRV14).
Blaas D; Kuechler E; Vriend G; Arnold E; Luo M; Rossmann MG
Proteins; 1987; 2(4):263-72. PubMed ID: 2834716
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus.
Phelps DK; Post CB
Protein Sci; 1999 Nov; 8(11):2281-9. PubMed ID: 10595531
[TBL] [Abstract][Full Text] [Related]
13. Human rhinovirus 14 complexed with antiviral compound R 61837.
Chapman MS; Minor I; Rossmann MG; Diana GD; Andries K
J Mol Biol; 1991 Feb; 217(3):455-63. PubMed ID: 1847215
[TBL] [Abstract][Full Text] [Related]
14. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.
Hadfield AT; Diana GD; Rossmann MG
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14730-5. PubMed ID: 10611281
[TBL] [Abstract][Full Text] [Related]
15. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
[TBL] [Abstract][Full Text] [Related]
16. Cryoelectron microscopy analysis of the structural changes associated with human rhinovirus type 14 uncoating.
Hewat EA; Blaas D
J Virol; 2004 Mar; 78(6):2935-42. PubMed ID: 14990711
[TBL] [Abstract][Full Text] [Related]
17. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
[TBL] [Abstract][Full Text] [Related]
18. A novel benzonitrile analogue inhibits rhinovirus replication.
Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
[TBL] [Abstract][Full Text] [Related]
19. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.
Rossmann MG
Antiviral Res; 1989 Feb; 11(1):3-13. PubMed ID: 2540708
[TBL] [Abstract][Full Text] [Related]
20. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
